104 related articles for article (PubMed ID: 8950344)
1. What is the best method of prevention of therapeutic failures in CNS in high risk retinoblastoma?
Grześkowiak-Melanowska J; Skoczeń S; Armata J
Med Pediatr Oncol; 1997 Jan; 28(1):79. PubMed ID: 8950344
[No Abstract] [Full Text] [Related]
2. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
Mathew AA; Sachdev N; Staffieri SE; McKenzie JD; Elder JE
J AAPOS; 2015 Feb; 19(1):72-4. PubMed ID: 25727592
[TBL] [Abstract][Full Text] [Related]
3. Diffuse infiltrating retinoblastoma with central nervous system metastasis.
Khetan V; Al-Kharusi N; Ganesh A; Al-Futaisi A; Biswas J; Kumar K; Raja T
Arch Ophthalmol; 2011 Mar; 129(3):375-7. PubMed ID: 21403001
[No Abstract] [Full Text] [Related]
4. Orbital recurrence of retinoblastoma successfully treated by combined therapy.
Goble RR; McKenzie J; Kingston JE; Plowman PN; Hungerford JL
Br J Ophthalmol; 1990 Feb; 74(2):97-8. PubMed ID: 2310733
[TBL] [Abstract][Full Text] [Related]
5. The role of chemotherapy in orbital involvement of retinoblastoma. The experience of a single institution with 33 patients.
Doz F; Khelfaoui F; Mosseri V; Validire P; Quintana E; Michon J; Desjardins L; Schlienger P; Neuenschwander S; Vielh P
Cancer; 1994 Jul; 74(2):722-32. PubMed ID: 8033054
[TBL] [Abstract][Full Text] [Related]
6. Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique.
Doz F; Neuenschwander S; Plantaz D; Courbon B; Gentet JC; Bouffet E; Mosseri V; Vannier JP; Mechinaud F; Desjardins L
J Clin Oncol; 1995 Apr; 13(4):902-9. PubMed ID: 7707117
[TBL] [Abstract][Full Text] [Related]
7. Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation.
Dimaras H; Héon E; Budning A; Doyle JJ; Halliday W; Gallie BL; Chan HS
Ophthalmic Genet; 2009 Sep; 30(3):121-6. PubMed ID: 19941416
[TBL] [Abstract][Full Text] [Related]
8. Response of orbital and central nervous system metastases of retinoblastoma following treatment with cyclophosphamide/doxorubicin.
Pratt CB; Kun LE
Pediatr Hematol Oncol; 1987; 4(2):125-30. PubMed ID: 3152919
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
[TBL] [Abstract][Full Text] [Related]
10. Combined high-dose intra-arterial and intrathecal chemotherapy for the treatment of a case of extraocular retinoblastoma.
Rodriguez A; Zugbi S; Requejo F; Deu A; Sampor C; Sgroi M; Bosaleh A; Fandiño A; Schaiquevich P; Chantada G
Pediatr Blood Cancer; 2018 Dec; 65(12):e27385. PubMed ID: 30105793
[TBL] [Abstract][Full Text] [Related]
11. Encouraging result of tamoxifen in a retinoblastoma patient with central nervous system metastasis.
Taçyildiz N; Yavuz G; Unal E; Gündüz K; Günalp I; Ekinci C
Pediatr Hematol Oncol; 2003 Sep; 20(6):473-6. PubMed ID: 14631622
[TBL] [Abstract][Full Text] [Related]
12. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R
Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
[TBL] [Abstract][Full Text] [Related]
13. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
14. Extraocular retinoblastoma: a 13-year experience.
Antoneli CB; Steinhorst F; de Cássia Braga Ribeiro K; Novaes PE; Chojniak MM; Arias V; de Camargo B
Cancer; 2003 Sep; 98(6):1292-8. PubMed ID: 12973854
[TBL] [Abstract][Full Text] [Related]
15. Outcome, pathologic findings, and compliance in orbital retinoblastoma (International Retinoblastoma Staging System stage III) treated with neoadjuvant chemotherapy: a prospective study.
Radhakrishnan V; Kashyap S; Pushker N; Sharma S; Pathy S; Mohanti BK; Vishnubhatla S; Ghose S; Bakhshi S
Ophthalmology; 2012 Jul; 119(7):1470-7. PubMed ID: 22463820
[TBL] [Abstract][Full Text] [Related]
16. Complications of systemic chemotherapy as treatment of retinoblastoma.
Benz MS; Scott IU; Murray TG; Kramer D; Toledano S
Arch Ophthalmol; 2000 Apr; 118(4):577-8. PubMed ID: 10766148
[No Abstract] [Full Text] [Related]
17. Lack of vincristine infiltrates in patients with retinoblastoma receiving chemotherapy by peripheral intravenous lines.
DiDomenico C; Clerico D; Leahey A
Pediatr Blood Cancer; 2015 Oct; 62(10):1859-61. PubMed ID: 25929686
[TBL] [Abstract][Full Text] [Related]
18. Metastatic retinoblastoma to the orofacial region.
Ebata K; Mizutani H; Kaneda T; Horibe K
J Oral Maxillofac Surg; 1991 Oct; 49(10):1120-3. PubMed ID: 1890525
[No Abstract] [Full Text] [Related]
19. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
[TBL] [Abstract][Full Text] [Related]
20. Phase II window of idarubicin in children with extraocular retinoblastoma.
Chantada GL; Fandiño A; Mato G; Casak S
J Clin Oncol; 1999 Jun; 17(6):1847-50. PubMed ID: 10561224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
